Clinical Trial Update: Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a trial evaluating LEP-F1 + GLA-SE in healthy adults and leprosy patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• LEP-F1 + GLA-SE

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Leprosy | Phase 1, Phase 2 | Status: UNKNOWN